23rd Annual Psychopharmacology Update 2024 covers topics such as:
- Evidence-based strategies for treating youth at familial risk for developing bipolar disorder
- The pros and cons of various pharmacotherapeutic options in depression, schizophrenia, bipolar disorders, ADHD and child and adolescent psychiatric disorders
- Evidence base involving the short- and long-term efficacy versus safety risks of antidepressants in patients with bipolar depression
- Relative outcomes after augmentation versus switching strategies in treatment-resistant depression
- Data relevant to the therapeutic profile of lithium vs. anticonvulsants in the treatment of bipolar disorder
- Differentiate bipolar disorder from ADHD even when they co-exist
23rd Annual Psychopharmacology Update 2024 brings together senior attendees with job titles such as:
- General psychiatrists
- Child and adolescent psychiatrists
- Nurse practitioners
- Geriatric psychiatrists
- Nurses
- Physician assistants
- Social workers
- Psychologists
- Other mental health professionals
23rd Annual Psychopharmacology Update 2024 might be held in Oct 2024.